Should the arteriovenous fistula be created before starting dialysis?: A decision analytic approach

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Hiremath, Swapnil ^a,b   Knoll, Greg ^a   Weinstein, Milton C ^b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTERY STEAL SYNDROME; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL DECISION MAKING; COHORT ANALYSIS; CONTROLLED STUDY; DIALYSIS; DISEASE COURSE; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HUMAN; INTERMETHOD COMPARISON; LIFE EXPECTANCY; MALE; MONTE CARLO METHOD; OBSERVATIONAL METHOD; PATIENT REFERRAL; PROBABILITY; PROCESS OPTIMIZATION; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR ACCESS; WATCHFUL WAITING; ARTERIOVENOUS SHUNT; CHRONIC KIDNEY FAILURE; COMPUTER SIMULATION; DECISION MAKING; DECISION SUPPORT SYSTEM; METHODOLOGY; RENAL REPLACEMENT THERAPY;

AGED; ARTERIOVENOUS FISTULA; ARTERIOVENOUS SHUNT, SURGICAL; COMPUTER SIMULATION; DECISION MAKING; DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MARKOV CHAINS; MONTE CARLO METHOD; PROBABILITY; RENAL DIALYSIS;

EID: 82855177825     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028453     Document Type: Article

References (43)

1. U.S.Renal Data System (2011) USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2011. www.usrds.org. Accessed 2011 Oct 4.
2. K/DOQI Workgroup (2002) Part 4. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis 39: S46-S75.
3. Besarab A, (2008) Resolved: Fistulas are preferred to grafts as initial vascular access for dialysis. Pro J Am Soc Nephrol 19: 1629-1631.
4. Murad MH, Sidawy AN, Elamin MB, Rizvi AZ, Flynn DN, et al. (2008) Timing of referral for vascular access placement: a systematic review. J Vasc Surg 48: 31S-33S.
5. Luxton G, (2010) The CARI guidelines. Timing of referral of chronic kidney disease patients to nephrology services (adult). Nephrology (Carlton) 15 (Suppl 1): S2-11.
6. K/DOQI Workgroup (2006) Clinical practice guidelines for vascular access. Am J Kidney Dis 48 (Suppl 1): S176-S247.
7. Besarab A, Brouwer D, (2004) Improving arteriovenous fistula construction: Fistula first initiative. Hemodial Int 8: 199-206.
8. Jindal K, Chan CT, Deziel C, Hirsch D, Soroka SD, et al. (2006) Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 17: S1-27.
9. Tordoir J, Canaud B, Haage P, Konner K, Basci A, et al. (2007) EBPG on Vascular Access. Nephrol Dial Transplant 22 (Suppl 2): ii88-117.
10. MacRae JM, Pandeya S, Humen DP, Krivitski N, Lindsay RM, (2004) Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms. Am J Kidney Dis 43: e17-e22.
11. Scheltinga MR, van HF, Bruijninckx CM, (2009) Time of onset in haemodialysis access-induced distal ischaemia (HAIDI) is related to the access type. Nephrol Dial Transplant.
12. Keough-Ryan TM, Kiberd BA, Cox JL, Thompson KJ, Clase CM, (2008) Development of end stage renal disease following an acute cardiac event. Kidney Int 74: 356-363.
13. Patel ST, Hughes J, Mills JL Sr, (2003) Failure of arteriovenous fistula maturation: an unintended consequence of exceeding dialysis outcome quality Initiative guidelines for hemodialysis access. J Vasc Surg 38: 439-445.
14. Beck JR, Pauker SG, (1983) The Markov process in medical prognosis. Med Decis Making 3: 419-458.
15. Hawkins N, Sculpher M, Epstein D, (2005) Cost-effectiveness analysis of treatments for chronic disease: using R to incorporate time dependency of treatment response. Med Decis Making 25: 511-519.
16. O'Hare AM, Bertenthal D, Walter LC, Garg AX, Covinsky K, et al. (2007) When to refer patients with chronic kidney disease for vascular access surgery: should age be a consideration? Kidney Int 71: 555-561.
17. Conway B, Webster A, Ramsay G, Morgan N, Neary J, Whitworth C, Harty J, (2009) Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease. Nephrol Dial Transplant 24: 1930-1937.
18. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305.
19. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH, (2004) Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164: 659-663.
20. Levin A, Djurdjev O, Beaulieu M, Er L, (2008) Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis 52: 661-671.
21. O'Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, et al. (2007) Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 18: 2758-2765.
22. Patel UD, Young EW, Ojo AO, Hayward RA, (2005) CKD progression and mortality among older patients with diabetes. Am J Kidney Dis 46: 406-414.
23. Roderick PJ, Atkins RJ, Smeeth L, Mylne A, Nitsch DD, et al. (2009) CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis 53: 950-960.
24. Bradbury BD, Chen F, Furniss A, Pisoni RL, Keen M, et al. (2009) Conversion of vascular access type among incident hemodialysis patients: description and association with mortality. Am J Kidney Dis 53: 804-814.
25. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK, (2001) Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 60: 1443-1451.
26. Moist LM, Trpeski L, Na Y, Lok CE, (2008) Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian Organ Replacement Registry 2001-2004. Clin J Am Soc Nephrol 3: 1726-1732.
27. Pastan S, Soucie JM, McClellan WM, (2002) Vascular access and increased risk of death among hemodialysis patients. Kidney Int 62: 620-626.
28. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG, (2004) Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 15: 477-486.
29. Xue JL, Dahl D, Ebben JP, Collins AJ, (2003) The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis 42: 1013-1019.
30. Huijbregts HJ, Bots ML, Wittens CH, Schrama YC, Moll FL, et al. (2008) Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol 3: 714-719.
31. Graham J, Hiremath S, Magner PO, Knoll GA, Burns KD, (2008) Factors influencing the prevalence of central venous catheter use in a Canadian haemodialysis centre. Nephrol Dial Transplant 23: 3585-3591.
32. Johannesson M, Pliskin JS, Weinstein MC, (1994) A note on QALYs, time tradeoff, and discounting. Med Decis Making 14: 188-193.
33. Davison SN, Jhangri GS, Feeny DH, (2008) Comparing the Health Utilities Index Mark 3 (HUI3) with the Short Form-36 Preference-Based SF-6D in Chronic Kidney Disease. Value Health.
34. Naimark DM, Bott M, Krahn M, (2008) The half-cycle correction explained: two alternative pedagogical approaches. Med Decis Making 28: 706-712.
35. Briggs AH, (2004) Statistical approaches to handling uncertainty in health economic evaluation. Eur J Gastroenterol Hepatol 16: 551-561.
36. O'Hare AM, Allon M, Kaufman JS, (2010) Whether and when to refer patients for predialysis AV fistula creation: complex decision making in the face of uncertainty. Semin Dial 23: 452-455.
37. Ng LJ, Chen F, Pisoni RL, Krishnan M, Mapes D, et al. (2011) Hospitalization risks related to vascular access type among incident US hemodialysis patients. Nephrol Dial Transplant 26: 3659-3666.
38. Vachharajani TJ, Moossavi S, Jordan JR, Vachharajani V, Freedman BI, et al. (2011) Re-evaluating the Fistula First Initiative in Octogenarians on Hemodialysis. Clin J Am Soc Nephrol 6: 1663-1667.
39. Canadian Institute for Health Information (2008) 2007 Annual Report-Treatment of End-Stage Organ Failure in Canada, 1996 to 2005 (Ottawa: CIHI, 2008).
40. Xue H, Lacson E Jr, Wang W, Curhan GC, Brunelli SM, (2010) Choice of vascular access among incident hemodialysis patients: a decision and cost-utility analysis. Clin J Am Soc Nephrol 5: 2289-2296.
41. Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, et al. (2002) Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 61: 305-316.
42. Barlow AD, Doughman TM, Warwick GL, Nicholson ML, (2008) A successful scheme for reducing waiting times for arteriovenous fistula formation. J Vasc Access 9: 129-132.
43. Xi W, Harwood L, Diamant MJ, Brown JB, Gallo K, et al. (2011) Patient attitudes towards the arteriovenous fistula: a qualitative study on vascular access decision making. Nephrol Dial Transplant 26: 3302-3308.